Enveric Biosciences Inc vs Jumia Technologies AG - ADR — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Jumia Technologies AG - ADR trades at $6.13 (market cap $719.58M). The key difference: Jumia Technologies AG - ADR is far larger — about 116.1× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ENVB | JMIA | |
|---|---|---|
Market Cap | $6.20M | $719.58M |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $14.60 |
52-Week Low | $1.27 | $5.69 |
Enterprise Value | $1.30M | $666.68M |
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →